PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.13%
Negative net income growth while BB stands at 14.36%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
8.60%
D&A growth well above BB's 6.67%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
49.57%
Some yoy growth while BB is negative at -43.63%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-2.17%
Negative yoy SBC while BB is 14.48%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
197.37%
Slight usage while BB is negative at -75.66%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
192.69%
AR growth of 192.69% while BB is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-144.74%
Negative yoy inventory while BB is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-123.61%
Negative yoy AP while BB is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
80.11%
Growth of 80.11% while BB is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
22.96%
Lower 'other non-cash' growth vs. BB's 178.32%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
107.17%
Operating cash flow growth above 1.5x BB's 7.11%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-34.01%
Both yoy lines negative, with BB at -10.96%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-107.25%
Negative yoy acquisition while BB stands at 114.26%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-144.13%
Both yoy lines negative, with BB at -72.14%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
64.22%
We have some liquidation growth while BB is negative at -65.93%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-92.84%
We reduce yoy other investing while BB is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-354.71%
Both yoy lines negative, with BB at -487.96%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
81.40%
Debt repayment growth of 81.40% while BB is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
112.88%
Stock issuance far above BB's 25.50%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
83.21%
Similar buyback growth to BB's 88.96%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.